Allon completes dosing for AL-108 Phase Ib clinical trial
November 1, 2006
Allon Therapeutics launches $8-million financing
October 25, 2006
Allon Therapeutics completes $9.0 million private placement
November 15, 200
Angiotech's Vascular Wrap(TM) trial results demonstrate reduced incidence of amputation
November 9, 2006
Angiotech Pharmaceuticals reports third quarter results
November 1, 2006
Angiotech Pharmaceuticals: TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
October 26, 2006
Angiotech Pharmaceuticals files preliminary short form prospectus and registration statement
October 25, 2006
Genzyme Completes Tender Offer for Outstanding Shares of AnorMED
November 7, 2006
Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review
November 7, 2006
Anormed Completes Enrollment in Phase III Trial for Mozobil on Schedule
October 23, 2006
AnorMED and Genzyme reach agreement on acquisition
October 17, 2006
Aspreva Pharmaceuticals Corporation (ASPV) Announces Preliminary Results Of Phase III Trial Of CellCept For Myasthenia Gravis; CellCept Fails To Show Effectiveness Against Neuromuscular Disease
October 26, 2006
BC Biotech: Federal Government Answers British Columbia’s Call for Stronger Patent Protection for Therapeutics
October 26, 2006
BioPartnering North America, BPN, Calls for Applications to Present
November 7, 2006
Cardiome Reports Third Quarter Results
November 13, 2006
Cardiome to Release Third Quarter Results
November 10, 2006
Cardiome to Present at Investor Conferences
October 31, 2006
Chemokine Therapeutics announces third quarter 2006 financial and operating results
November 14, 2006
enGene, Inc. Introduces New GEMS'TM' Non-Viral Gene Delivery Technology and Initiates Series A Financing
October 17, 2006
Forbes Medi-Tech Announces Third Quarter 2006 Financial Results ~Company Reports 29% Increase in Revenues: Strong Contribution from Forbes Fayrefield Ltd; US Phase II Trial Topline Results Expected Within First Two Weeks of December~
November 14, 2006
Forbes Medi-Tech Announces the Expansion of Reducol™-based Products at Tesco Stores Ltd ~UK’s Largest Retailer Adds Strawberry Flavored Yogurt Drink to Range of Cholesterol-lowering Products~
November 2, 2006
Forbes Medi-Tech Closes TheraPei Acquisition
October 27, 2006
Forbes Medi-Tech to Present at Rodman & Renshaw 8th Annual Healthcare Conference
October 26, 2006
Forbes Medi-Tech to Acquire San Diego Based TheraPei Pharmaceuticals and Appoint Dr. John Nestor as Chief Scientific Officer
October 25, 2006
University of Leuven Selects GenoLogics Solution for Lab and Data Management
November 15, 2006
iCo Therapeutics Welcomes Dr. David S. Boyer to Strategic Advisory Board
October 27, 2006
Inflazyme Pharmaceuticals Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006
November 14, 2006
Inflazyme to Host Conference Call to Discuss Shareholder Letter and Second Quarter 2006 Financial Results
November 10, 2006
Inflazyme Successfully Completes Patient Enrolment in Phase IIb Trial with IPL512,602 in Asthma
November 8, 2006
NSERC-Pacific Press Release
November 14, 2006
Ondine Biopharma announces the closing of public offering
November 9, 2006
Ondine Biopharma announces filing of final short form prospectus
November 3, 2006
Ondine Biopharma announces filing of preliminary short form prospectus
October 24, 2006
Ondine Biopharma announces C$10 million "bought deal" financing
October 20, 2006
Pfizer Chairman Hank McKinnell receives the Grand Cordon of the Order of the Rising Sun Decoration from Emperor Akihito
November 7, 2006
Protox Announces Private Placement
October 25, 2006
QLT announces Q3 results for 2006, updates guidance, and implements cost reductions
October 26, 2006
Philip Blake Appointed New Chairman, Rx&D Board of Directors
November 15, 2006
UVIC Researchers Play $4-Million Role in Breast Cancer Study
November 8, 2006
Brain Gain: UVIC Attracts Scientific Star from the U.S.
October 25, 2006
Welichem Biotech Inc. Announces Investor Relations Appointment
October 23, 2006
Zymeworks announces key addition to its Board of Directors
October 23, 2006 |
